
@HFSP Postdoctoral Research Fellow @UMG #transcription #chromatin #aging #gene regulation
Göttingen, Germany
Joined April 2019
- Tweets71
- Following398
- Followers176
- Likes2.2K
Pinned Tweet
Happy and deeply honored to see my name on this @HFSP list! #HFSPFellowships
Looking forward to some exciting research in @AkisPapantonis lab!
🔜🔜🔜
And here it is, the CLASS OF 2024!🤩💪Congratulations to the 59 top emerging postdoctoral scientists awarded 2024 #HFSPFellowships!🥳🎉Are you one of them?🫵Discover the #frontierprojects that will foster next generation of #lifesciences👏bit.ly/3VKe7wM #2024HFSPAwardees
Anastasios Liakos retweeted
Together with @AndreasBeyer012, @AntebiLab, and Linda Partridge we wrote Opinion article in @TrendsCellBio on accumulating data relating age-associated changes in transcriptional elongation with homeostatic deregulation. Feedback welcome!
cell.com/trends/cell-biology…
An excellent opportunity for those interested in cancer immunology!
💥Exciting @ERC_Research funded postdoc opportunities in my lab at @CRUK_MI to study nutrient-host-microbiome interactions in cancer immunity in mice and humans. #CancerImmunology #MucosalImmunology #Microbiome
⏰Deadline: 1 December 2024
Apply 👇
cruk.manchester.ac.uk/recrui…
⏩RT
What a nice way to say goodbye!
Our latest work is now online on @AgingCell. Our study shows how Cockayne Syndrome B protein is implicated in transcription and chromatin dynamics in homeostatic and genotoxic conditions! onlinelibrary.wiley.com/doi/…
So proud of you, my friend! Well deserved!🥳🥳🥳
I feel extremely honoured to have been awarded an ERC starting grant #ERCStG to pursue our work on nutrient-host-microbiome interactions in cancer immunity @CRUK_MI. Thank you @ERC_Research for this incredible opportunity. Postdoc positions to be announced soon💥 #WatchThisSpace
Anastasios Liakos retweeted
Our lab (papantonislab.eu) is still looking for a PhD candidate with a strong computational biology background and a keen interest for genome assembly and #3Dgenomics to join our subproject in the exciting EvoREST initiative on genome evolution. @yourUMG @uniGoettingen
Anastasios Liakos retweeted
Hear! Hear!
Our lab @yourUMG is looking to add two curious, motivated PhD students to our team. One to work on disease #3Dgenomics, and one with a strong #bioinformatics background - both as part of newly-funded consortia. Please spread the word!
So proud of you, my friend @giampazolias !!!
Very excited to share our latest work, out today in @ScienceMagazine, on the serendipitous finding that vitamin D ☀️ regulates the gut microbiome to promote cancer immunity🦠 science.org/doi/10.1126/scie… 🧵👇 @ReiseSousaLab @TheCrick
Anastasios Liakos retweeted
Περισσότερο από "2η Έκδοση" είναι ένα καινούργιο βιβλίο, με πέντε νέα κεφάλαια, επικαιροποιημενο υλικό, ερωτήσεις, ασκήσεις και θέματα εργασιών. Μεγάλο φορμάτ, εντυπωσιακό artwork.
Το έγραψα στους μήνες του χειμωνιατικου Μουντιάλ αλλά τώρα που το βλέπω, νομίζω ότι άξιζε.
#R
Anastasios Liakos retweeted
Yes! It's public! Our lab's new work providing the first evidence of spatial spreading of intestinal inflammation via distinct fibroblast subsets. Amazing work .. all because of amazing Lida et al! @BSRC_Fleming @CrohnsColitisFn @ERC_Research biorxiv.org/content/10.1101/…
Anastasios Liakos retweeted
🎯Exciting news for the Gene Control Mechanisms lab @IMBB_FORTH: We have secured funding to recruit a bioinformatician or a computational biologist to analyse multi-omic data and decipher molecular mechanisms ruling RNA transcription and DNA repair in human health vs pathology!
Proud and extremely happy to see our recent work published today @NAR_Open! Congratulations to all the (past and present) members of the #MFlab @BSRC_Fleming that contributed!
academic.oup.com/nar/advance…
Anastasios Liakos retweeted
💥Exciting postdoc opportunity in my lab at @CRUK_MI
to study host-microbiome interactions in anti-cancer immunity.
⏰⏰⏰Deadline approaching soon: 17 July 2023
💥If you are interested in cancer immunology don't miss the opportunity! Apply👇
cruk.manchester.ac.uk/recrui…
Anastasios Liakos retweeted
msca.b2match.io/participatio…
Looking for a mentor and host lab for MSCA-PF2023?
Hurry up ! We can still make it!😉
Get in touch with me if interested in mechanisms of transcription regulation, chromatin modification, nascent RNAs and how their deregulation occurs in cancer or neuropathies. Both molecular and mathematical biologists profiles are welcome! We are in Greece 🇬🇷 at @IMBB_FORTH
Anastasios Liakos retweeted
@BSRC_Fleming @pintofscienceGR 2023! Join us for a drink & learn about the secrets of our #genome #Nikolaou_lab, 29/5 - how #evolution affects our everyday lives @vakirlis, 29/5 - how our #cells decide what they want to be @verykokakis 31/5 @ #MoMix_bar! fleming.gr/impact/fleming-hi…
Anastasios Liakos retweeted
An antipsychotic drug reduces arthritis in a fibroblast dependent model! Take a look on our work from @KolliasLab at @BSRC_Fleming published now in @JCI_insight. Thanks to our collaborators @Biomedcode @JesperOlsenLab
Repurposing the antipsychotic drug amisulpride for targeting synovial fibroblast activation in arthritis: buff.ly/42mYXhy
@KolliasLab @BSRC_Fleming
#Therapeutics
Anastasios Liakos retweeted
Farewell to our beloved @CharaKonst, who is joining the greek scientific community in the 🚴☔🌦️ Netherlands. Good luck and see you soon again 🙂
Anastasios Liakos retweeted
What is this? This is a pipette!!! To @BSRC_Fleming πάει #RoukZouk και διδάσκει μοριακή βιολογία!!!
Anastasios Liakos retweeted
Happy that our work at @KolliasLab in @BSRC_Fleming is now available as a preprint! @biorxivpreprint #arthritis #fibroblasts #DrugRepurposing
Repurposing of Amisulpride, a known antipsychotic drug, to target synovial fibroblasts activation in arthritis. biorxiv.org/cgi/content/shor… #bioRxiv
Anastasios Liakos retweeted
Thrilled to share our latest collaborative work with @KolliasLab & #FousteriLab, which advances our understanding of synovial fibroblast heterogeneity in homeostasis and inflammatory arthritis (RA). It is now published @GenomeMedicine (rdcu.be/cSn6w)




























